RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Celltrion Healthcare Co Stock

Celltrion Healthcare Co Revenue 2024

Celltrion Healthcare Co Revenue

3.01 T KRW

Ticker

091990.KQ

ISIN

KR7091990002

In 2024, Celltrion Healthcare Co's sales reached 3.01 T KRW, a 25.66% difference from the 2.4 T KRW sales recorded in the previous year.

The Celltrion Healthcare Co Revenue history

YEARREVENUE (undefined KRW)GROSS MARGIN (%)
2026e3.9714,14
2025e3.2217,43
2024e3.0118,64
2023e2.423,43
20221.9728,48
20211.823,86
20201.6333,29
20191.119,01
20180.719,65
20170.9224,34
20160.7326,65
20150.437,19
20140.1641,86

Celltrion Healthcare Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Celltrion Healthcare Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Celltrion Healthcare Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Celltrion Healthcare Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Celltrion Healthcare Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Celltrion Healthcare Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Celltrion Healthcare Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Celltrion Healthcare Co’s growth potential.

Celltrion Healthcare Co Revenue, EBIT and net profit per share

DateCelltrion Healthcare Co RevenueCelltrion Healthcare Co EBITCelltrion Healthcare Co Net Income
2026e3.97 T KRW584.75 B KRW447.83 B KRW
2025e3.22 T KRW605.61 B KRW424.03 B KRW
2024e3.01 T KRW348.48 B KRW275.99 B KRW
2023e2.4 T KRW230.77 B KRW192.56 B KRW
20221.97 T KRW228.89 B KRW147.18 B KRW
20211.8 T KRW199.44 B KRW152.57 B KRW
20201.63 T KRW362.11 B KRW240.41 B KRW
20191.1 T KRW82.79 B KRW64.96 B KRW
2018713.49 B KRW-25.2 B KRW11.39 B KRW
2017920.92 B KRW153.65 B KRW157.44 B KRW
2016733.26 B KRW155.3 B KRW97.17 B KRW
2015402.39 B KRW111.91 B KRW20.58 B KRW
2014164.74 B KRW37.32 B KRW-369.99 B KRW

Celltrion Healthcare Co stock margins

The Celltrion Healthcare Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Celltrion Healthcare Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Celltrion Healthcare Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Celltrion Healthcare Co's sales revenue. A higher gross margin percentage indicates that the Celltrion Healthcare Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Celltrion Healthcare Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Celltrion Healthcare Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Celltrion Healthcare Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Celltrion Healthcare Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Celltrion Healthcare Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Celltrion Healthcare Co Margin History

Celltrion Healthcare Co Gross marginCelltrion Healthcare Co Profit marginCelltrion Healthcare Co EBIT marginCelltrion Healthcare Co Profit margin
2026e28.48 %14.72 %11.27 %
2025e28.48 %18.79 %13.16 %
2024e28.48 %11.56 %9.16 %
2023e28.48 %9.62 %8.03 %
202228.48 %11.61 %7.46 %
202123.86 %11.05 %8.45 %
202033.29 %22.25 %14.77 %
201919.01 %7.52 %5.9 %
20189.65 %-3.53 %1.6 %
201724.34 %16.68 %17.1 %
201626.65 %21.18 %13.25 %
201537.19 %27.81 %5.12 %
201441.86 %22.66 %-224.59 %

Celltrion Healthcare Co Aktienanalyse

What does Celltrion Healthcare Co do?

Celltrion Healthcare Co Ltd is a leading South Korean biopharmaceutical company that focuses on the development and manufacturing of biological drugs for the treatment of severe and complex diseases. The company was founded in 2009 and is headquartered in Incheon, South Korea. Celltrion Healthcare Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Celltrion Healthcare Co's Sales Figures

The sales figures of Celltrion Healthcare Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Celltrion Healthcare Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Celltrion Healthcare Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Celltrion Healthcare Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Celltrion Healthcare Co stock

How much revenue did Celltrion Healthcare Co generate this year?

Celltrion Healthcare Co has achieved a revenue of 3.01 T KRW this year.

How much was the turnover of the company Celltrion Healthcare Co compared to the previous year?

The revenue of Celltrion Healthcare Co has increased by 25.66% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Celltrion Healthcare Co?

The revenue of Celltrion Healthcare Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Celltrion Healthcare Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Celltrion Healthcare Co so important for investors?

The revenue of Celltrion Healthcare Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Celltrion Healthcare Co pay?

Over the past 12 months, Celltrion Healthcare Co paid a dividend of 125 KRW . This corresponds to a dividend yield of about 0.16 %. For the coming 12 months, Celltrion Healthcare Co is expected to pay a dividend of 132.37 KRW.

What is the dividend yield of Celltrion Healthcare Co?

The current dividend yield of Celltrion Healthcare Co is 0.16 %.

When does Celltrion Healthcare Co pay dividends?

Celltrion Healthcare Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Celltrion Healthcare Co?

Celltrion Healthcare Co paid dividends every year for the past 6 years.

What is the dividend of Celltrion Healthcare Co?

For the upcoming 12 months, dividends amounting to 132.37 KRW are expected. This corresponds to a dividend yield of 0.17 %.

In which sector is Celltrion Healthcare Co located?

Celltrion Healthcare Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Celltrion Healthcare Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Celltrion Healthcare Co from 3/1/2023 amounting to 125 KRW, you needed to have the stock in your portfolio before the ex-date on 12/28/2022.

When did Celltrion Healthcare Co pay the last dividend?

The last dividend was paid out on 3/1/2023.

What was the dividend of Celltrion Healthcare Co in the year 2023?

In the year 2023, Celltrion Healthcare Co distributed 125 KRW as dividends.

In which currency does Celltrion Healthcare Co pay out the dividend?

The dividends of Celltrion Healthcare Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Celltrion Healthcare Co

Our stock analysis for Celltrion Healthcare Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Celltrion Healthcare Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.